126 related articles for article (PubMed ID: 9043657)
1. Regulation of stress-induced cytokine production by pyridinylimidazoles; inhibition of CSBP kinase.
Gallagher TF; Seibel GL; Kassis S; Laydon JT; Blumenthal MJ; Lee JC; Lee D; Boehm JC; Fier-Thompson SM; Abt JW; Soreson ME; Smietana JM; Hall RF; Garigipati RS; Bender PE; Erhard KF; Krog AJ; Hofmann GA; Sheldrake PL; McDonnell PC; Kumar S; Young PR; Adams JL
Bioorg Med Chem; 1997 Jan; 5(1):49-64. PubMed ID: 9043657
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine kinase and c-Jun NH2-terminal kinase mediate hypertrophic responses to prostaglandin F2alpha in cultured neonatal rat ventricular myocytes.
Adams JW; Sah VP; Henderson SA; Brown JH
Circ Res; 1998 Jul; 83(2):167-78. PubMed ID: 9686756
[TBL] [Abstract][Full Text] [Related]
3. Pyrimidinylimidazole inhibitors of CSBP/p38 kinase demonstrating decreased inhibition of hepatic cytochrome P450 enzymes.
Adams JL; Boehm JC; Kassis S; Gorycki PD; Webb EF; Hall R; Sorenson M; Lee JC; Ayrton A; Griswold DE; Gallagher TF
Bioorg Med Chem Lett; 1998 Nov; 8(22):3111-6. PubMed ID: 9873686
[TBL] [Abstract][Full Text] [Related]
4. p38 mitogen-activated protein kinase and c-jun-NH2-terminal kinase regulate RANTES production by influenza virus-infected human bronchial epithelial cells.
Kujime K; Hashimoto S; Gon Y; Shimizu K; Horie T
J Immunol; 2000 Mar; 164(6):3222-8. PubMed ID: 10706714
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotective effect afforded by transient exposure to phosphodiesterase III inhibitors: the role of protein kinase A and p38 mitogen-activated protein kinase.
Sanada S; Kitakaze M; Papst PJ; Asanuma H; Node K; Takashima S; Asakura M; Ogita H; Liao Y; Sakata Y; Ogai A; Fukushima T; Yamada J; Shinozaki Y; Kuzuya T; Mori H; Terada N; Hori M
Circulation; 2001 Aug; 104(6):705-10. PubMed ID: 11489779
[TBL] [Abstract][Full Text] [Related]
6. Coordinated regulation of radioadaptive response by protein kinase C and p38 mitogen-activated protein kinase.
Shimizu T; Kato T; Tachibana A; Sasaki MS
Exp Cell Res; 1999 Sep; 251(2):424-32. PubMed ID: 10471327
[TBL] [Abstract][Full Text] [Related]
7. Role of CSB/p38/RK stress response kinase in LPS and cytokine signaling mechanisms.
Lee JC; Young PR
J Leukoc Biol; 1996 Feb; 59(2):152-7. PubMed ID: 8603987
[TBL] [Abstract][Full Text] [Related]
8. Involvement of p38 mitogen-activated protein kinase in heat shock protein 27 induction in human neutrophils.
Niwa M; Hotta K; Kanamori Y; Hatakeyama D; Hirade K; Katayama M; Hara A; Mori H; Ito H; Kato K; Matsuno H; Uematsu T; Kozawa O
Eur J Pharmacol; 2003 Apr; 466(3):245-53. PubMed ID: 12694807
[TBL] [Abstract][Full Text] [Related]
9. Calmodulin-dependent activation of p38 and p42/44 mitogen-activated protein kinases contributes to c-fos expression by calcium in PC12 cells: modulation by nitric oxide.
Lee SA; Park JK; Kang EK; Bae HR; Bae KW; Park HT
Brain Res Mol Brain Res; 2000 Jan; 75(1):16-24. PubMed ID: 10648884
[TBL] [Abstract][Full Text] [Related]
10. Involvement of protein kinase C, p38 MAP kinase and ERK in arachidonic acid-stimulated superoxide production in human neutrophils.
Hii CS; Huang ZH; Bilney A; Stacey K; Murray AW; Rathjen DA; Ferrante A
Adv Exp Med Biol; 1999; 469():365-70. PubMed ID: 10667354
[No Abstract] [Full Text] [Related]
11. A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase.
Fox T; Coll JT; Xie X; Ford PJ; Germann UA; Porter MD; Pazhanisamy S; Fleming MA; Galullo V; Su MS; Wilson KP
Protein Sci; 1998 Nov; 7(11):2249-55. PubMed ID: 9827991
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase.
Tamir A; Granot Y; Isakov N
J Immunol; 1996 Aug; 157(4):1514-22. PubMed ID: 8759733
[TBL] [Abstract][Full Text] [Related]
13. Use of a drug-resistant mutant of stress-activated protein kinase 2a/p38 to validate the in vivo specificity of SB 203580.
Eyers PA; van den IJssel P; Quinlan RA; Goedert M; Cohen P
FEBS Lett; 1999 May; 451(2):191-6. PubMed ID: 10371163
[TBL] [Abstract][Full Text] [Related]
14. SAR of 4-hydroxypiperidine and hydroxyalkyl substituted heterocycles as novel p38 map kinase inhibitors.
Revesz L; Di Padova FE; Buhl T; Feifel R; Gram H; Hiestand P; Manning U; Zimmerlin AG
Bioorg Med Chem Lett; 2000 Jun; 10(11):1261-4. PubMed ID: 10866395
[TBL] [Abstract][Full Text] [Related]
15. p38 but not p44/42 mitogen-activated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages.
Chen CC; Wang JK
Mol Pharmacol; 1999 Mar; 55(3):481-8. PubMed ID: 10051531
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological effects of SB 220025, a selective inhibitor of P38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models.
Jackson JR; Bolognese B; Hillegass L; Kassis S; Adams J; Griswold DE; Winkler JD
J Pharmacol Exp Ther; 1998 Feb; 284(2):687-92. PubMed ID: 9454815
[TBL] [Abstract][Full Text] [Related]
17. Glucose transporter expression in L6 muscle cells: regulation through insulin- and stress-activated pathways.
Taha C; Tsakiridis T; McCall A; Klip A
Am J Physiol; 1997 Jul; 273(1 Pt 1):E68-76. PubMed ID: 9252481
[TBL] [Abstract][Full Text] [Related]
18. The activation state of p38 mitogen-activated protein kinase determines the efficiency of ATP competition for pyridinylimidazole inhibitor binding.
Frantz B; Klatt T; Pang M; Parsons J; Rolando A; Williams H; Tocci MJ; O'Keefe SJ; O'Neill EA
Biochemistry; 1998 Sep; 37(39):13846-53. PubMed ID: 9753474
[TBL] [Abstract][Full Text] [Related]
19. SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence.
Underwood DC; Osborn RR; Kotzer CJ; Adams JL; Lee JC; Webb EF; Carpenter DC; Bochnowicz S; Thomas HC; Hay DW; Griswold DE
J Pharmacol Exp Ther; 2000 Apr; 293(1):281-8. PubMed ID: 10734180
[TBL] [Abstract][Full Text] [Related]
20. Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles.
Kumar S; McDonnell PC; Gum RJ; Hand AT; Lee JC; Young PR
Biochem Biophys Res Commun; 1997 Jun; 235(3):533-8. PubMed ID: 9207191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
